This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Hold MAXIMUS (MMS) in Your Portfolio
by Zacks Equity Research
Strong balance sheet and financial flexibility aid MAXIMUS (MMS) stock. Meanwhile, global presence makes the company vulnerable to foreign currency exchange rate fluctuations.
MAXIMUS (MMS) Beats on Q1 Earnings, Raises 2021 Guidance
by Zacks Equity Research
MAXIMUS (MMS) first-quarter fiscal 2021 earnings and revenues increase year over year.
Maximus (MMS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 9.57% and 8.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Maximus' (MMS) first-quarter fiscal 2021 earnings and revenues are likely to have increased year over year.
Maximus (MMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain MAXIMUS (MMS) Stock in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) has a diversified portfolio with high operating profit margin, high cash conversion and access to a $400 million credit facility.
How Has MMS Performed 30 Days Post Earnings
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Stock Declines 2.1% Since Q4 Earnings Release
by Zacks Equity Research
MAXIMUS (MMS) fourth-quarter fiscal 2020 results benefit from new work and expansion of existing contracts.
Maximus (MMS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 12.09% and 6.67%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Maximus (MMS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain MAXIMUS (MMS) Stock in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) maintains solid relationships and strong reputation with governments and long-term contracts provide it with predictable recurring-revenue streams.
Should Value Investors Consider MAXIMUS (MMS) Stock Now?
by Zacks Equity Research
Let's see if MAXIMUS stock is a good choice for value-oriented investors right now from multiple angles.
Maximus Augments Contact Tracing Programs in Five States
by Zacks Equity Research
MAXIMUS's (MMS) financial performance is being boosted by its COVID-19-response work such as contact tracing and assistance with unemployment benefits.
Here's Why Investors Should Hold on to MAXIMUS (MMS) Stock
by Zacks Equity Research
Technology investments and strong capabilities in citizen engagement and complex program administration make MAXIMUS (MMS) a trusted partner to governments.
Why Is Maximus (MMS) Down 1.9% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Rides on Government Contracts, Debt Woe Stays
by Zacks Equity Research
With more than 40 years of experience, MAXIMUS (MMS) has grown to be a leading operator of government health and human-services programs globally.
Maximus (MMS) Beats on Earnings in Q3, Declines Marginally
by Zacks Equity Research
New work and expansion of existing contracts owing to COVID-19 drive MAXIMUS's (MMS) third-quarter fiscal 2020 results.
Maximus (MMS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 33.33% and 11.03%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Maximus (MMS) Q3 Earnings Expected to Decline
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Maximus (MMS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MAXIMUS, VA Ready Partner to Combat Job Loss in Virginia
by Zacks Equity Research
MAXIMUS (MMS) becomes VA Ready's business partner to extend support, input and participation in the process of helping unemployed Virginians find jobs.
Here's Why You Should Retain MAXIMUS (MMS) in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) maintains solid relationships and strong reputation with governments, and long-term contracts provide it with predictable recurring revenue streams.
Why Is Maximus (MMS) Up 13% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Misses on Q2 Earnings Amid Coronavirus Crisis
by Zacks Equity Research
MAXIMUS (MMS) second-quarter fiscal 2020 earnings hurt by COVID-19 outbreak. However, revenue increased year on year owing to organic growth.
Maximus (MMS) Misses Q2 Earnings Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of -43.42% and 9.63%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?